Follow Us on StockTwits

Forget Top Penny Stocks, Biotech ETF Looks Like the Better Play

Posted by on July 12, 2017 10:30 PM
Tags: , , , ,
Categories: Stocks To Watch

I love penny stocks but here’s a setup so juicy I say forget gambling on top penny stocks, just go for the SPDR S&P Biotech ETF XBI. The chart of XBI looks pretty awesome for a swing long trade.

I spend a lot of time searching through small cap biotech stocks but I have to say, this biotech ETF chart seems to beat them all with a lot less risk too.

Jason Bond Sponsor

Biotech ETF Instead of Top Penny Stocks

Don’t get me wrong, I will keep looking for good biotech penny plays but the ETF XBI looks like a lower risk setup to play.

Top penny stocks, nah, instead lower risk XBI

XBI looks like a decent setup on a Bull Flag pattern. Over the last 12 trading days, we’ve had three pocket pivot signals which is bullish.

The Effective Volume indicator shows a beautiful positive divergence between large volume orders and price action, another bullish indicator.

There is reduced volatility while prices have been consolidating but we don’t yet have a momentum squeeze setup.

stocks-to-watch xbi stock chart 1100x823 - Forget Top Penny Stocks, Biotech ETF Looks Like the Better Play

The True Strength Index is starting to round out but we don’t yet have a bullish cross.

jb2

Who needs top penny stocks when a safer ETF sets up like XBI? Still, it’s biotechs so be careful and really get that good entry. A good entry is the difference between a winning and losing trade.

GO HERE TO CHART LARGE PLAYERS AND THE TWIGGS MONEY FLOW LIKE THE CHART ABOVE… AWESOME TOOL

Biotech ETF XBI Review
  • Technical Rating (trend, yearly performance, relative strength, distance to 52 week high/low)
  • Setup (consolidation, support/resistance, pocket pivots, large player volume)
4.5

Summary

XBI seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.

Sending
User Rating 0 (0 votes)

Leave a Reply